LifeSpeak Valuation

Is 81F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 81F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 81F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 81F's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 81F?

Key metric: As 81F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 81F. This is calculated by dividing 81F's market cap by their current revenue.
What is 81F's PS Ratio?
PS Ratio0.4x
SalesCA$49.57m
Market CapCA$21.88m

Price to Sales Ratio vs Peers

How does 81F's PS Ratio compare to its peers?

The above table shows the PS ratio for 81F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.7x
SLSA Solutiance
2.7xn/a€14.4m
R1B Rubean
23.6x55.3%€19.9m
CLIQ Cliq Digital
0.09x13.2%€24.7m
LSX LS telcom
0.5x5.0%€20.3m
81F LifeSpeak
0.4x1.8%€21.9m

Price-To-Sales vs Peers: 81F is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (6.7x).


Price to Sales Ratio vs Industry

How does 81F's PS Ratio compare vs other companies in the DE Software Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.2.2x10.6%
81F LifeSpeak
0.4x1.8%US$15.65m
CSH CENIT
0.4x5.2%US$73.94m
CLIQ Cliq Digital
0.09x13.2%US$25.72m
81F 0.4xIndustry Avg. 2.2xNo. of Companies7PS02.44.87.29.612+
8 CompaniesEstimated GrowthMarket Cap
Industry Avg.2.2x39.7%
81F LifeSpeak
0.4x42.6%US$15.65m
No more companies

Price-To-Sales vs Industry: 81F is good value based on its Price-To-Sales Ratio (0.4x) compared to the German Software industry average (1.8x).


Price to Sales Ratio vs Fair Ratio

What is 81F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

81F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ratio1.1x

Price-To-Sales vs Fair Ratio: 81F is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 81F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.24
€0.24
+2.0%
29.9%€0.34€0.14n/a4
Nov ’25€0.24
€0.29
+21.1%
28.2%€0.40€0.17n/a5
Oct ’25€0.32
€0.29
-9.8%
28.2%€0.40€0.17n/a5
Sep ’25€0.30
€0.30
-1.1%
25.7%€0.40€0.17n/a6
Aug ’25€0.27
€0.34
+27.5%
22.4%€0.41€0.24n/a6
Jul ’25€0.25
€0.34
+35.6%
22.4%€0.41€0.24n/a6
Jun ’25€0.31
€0.34
+10.8%
22.4%€0.41€0.24n/a6
May ’25€0.42
€0.40
-4.1%
32.5%€0.61€0.24n/a6
Apr ’25€0.45
€0.40
-10.2%
32.5%€0.61€0.24n/a6
Mar ’25€0.38
€0.37
-2.7%
35.7%€0.61€0.24n/a7
Feb ’25€0.42
€0.37
-11.9%
35.7%€0.61€0.24n/a7
Jan ’25€0.43
€0.37
-13.5%
35.7%€0.61€0.24n/a7
Dec ’24€0.37
€0.37
-0.1%
35.7%€0.61€0.24n/a7
Nov ’24€0.26
€0.49
+87.0%
29.8%€0.75€0.34€0.247
Oct ’24€0.31
€0.49
+61.3%
29.8%€0.75€0.34€0.327
Sep ’24€0.40
€0.49
+24.0%
29.8%€0.75€0.34€0.307
Aug ’24€0.39
€0.52
+35.2%
26.3%€0.75€0.34€0.277
Jul ’24€0.27
€0.52
+95.7%
26.3%€0.75€0.34€0.257
Jun ’24€0.30
€0.52
+73.6%
26.3%€0.75€0.34€0.317
May ’24€0.25
€0.68
+177.7%
24.4%€1.00€0.50€0.427
Apr ’24€0.38
€1.09
+191.0%
39.7%€1.71€0.51€0.457
Mar ’24€0.43
€1.28
+196.1%
28.7%€1.73€0.73€0.387
Feb ’24€0.58
€1.45
+151.1%
31.4%€2.18€0.76€0.428
Jan ’24€0.60
€1.45
+141.5%
31.4%€2.18€0.76€0.438
Dec ’23€0.58
€1.45
+151.6%
31.4%€2.18€0.76€0.378
Nov ’23€0.95
€2.29
+140.2%
29.8%€3.42€1.14€0.268

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies